Home » Advanced Oncotherapy (AVO) » Advanced Oncotherapy (AVO) looking at “disrupting” the cancer treatment market
In a Proactive StockTube interview, Nicolas Serandour, chief operating officer (COO) and chief finance officer (CFO) Advanced Oncotherapy (AVO), says the firm is looking at “disrupting the market” with its proton cancer treatment technology.
Tags: advanced oncotherapy, avo, nicolas serandour, proactive investors, proton beam therapy, stocktube
You must be logged in to post a comment.
Powered by WordPress / Academica WordPress Theme by WPZOOM